Skip to main content
Premium Trial:

Request an Annual Quote

BioCat to Distribute Kreatech s Labeling Tech in Germany, Switzerland, Austria

NEW YORK, Sept. 14 (GenomeWeb News) - Kreatech Biotechnology has signed up BioCat to distribute its molecular labeling technology in Germany, Switzerland, and Austria, the Amsterdam-based company said today.


Under the agreement, BioCat, located in Heidelberg, Germany, will supply Kreatech's Universal Linkage System, which allows users to attach a variety of labels to DNA, RNA, or proteins, to laboratories in Germany, Switzerland, and Austria.


Kreatech said it expects to expand its distribution network further in the next few month, both in Europe and Asia.

The Scan

Study Follows Consequences of Early Confirmatory Trials for Accelerated Approval Indications

Time to traditional approval or withdrawal was shorter when confirmatory trials started prior to accelerated approval, though overall regulatory outcomes remained similar, a JAMA study finds.

Sequencing Study Leads to Vaccine Target in Bacteria Behind Neonatal Meningitis

Researchers eBioMedicine track down potential vaccine targets with transposon sequencing on mutant bacteria causing neonatal meningitis in mouse models of the disease.

Multiple Myeloma Progression Influenced by Immune Microenvironment Expression

Researchers in NPJ Genomic Medicine compare RNA sequencing profiles of 102,207 individual cells in bone marrow samples from 18 individuals with rapid or non-progressing multiple myeloma.

Self-Reported Hearing Loss in Older Adults Begins Very Early in Life, Study Says

A JAMA Otolaryngology — Head & Neck Surgery study says polygenic risk scores associated with hearing loss in older adults is also associated with hearing decline in younger groups.